No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas.

Ménard, S

No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas. [electronic resource] - Journal of the National Cancer Institute Jul 1996 - 1002-3 p. digital

Publication Type: Letter

0027-8874

10.1093/jnci/88.14.1002 doi


Breast Neoplasms--genetics
Female
Genes, erbB-2--genetics
Genes, p53--genetics
Humans
Immunohistochemistry
Lymphatic Metastasis
Mutation
Neoplasm Staging
Receptor, ErbB-2--genetics
Survival Analysis
Tumor Suppressor Protein p53--genetics